With two antiviral pills, from Pfizer and Merck, now cleared to treat Covid-19, many health experts see a shift in the fight against the virus, but not right away.
"Will people who are at the greatest risk of getting infected actually be able to seek care, have a rapid turnaround time for a diagnostic test, have access to these drugs and then initiate one of these medications in a timely matter?" Dr. Isaac Bogoch, an infectious disease physician at the University of Toronto, said."Unfortunately, I think these medications may be out of reach for many people" in the short term.
"People should know this is not something that is just for anyone, that you can just run to your local drugstore and pick up off the shelf," she said, adding that these are not"miracle pills." They're not recommended for everyone, and both drugs come with risks for certain groups. Pfizer's treatment was found in clinical trials to be more effective than Merck's in high-risk populations — 89 percent efficacy versus 30 percent.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA authorizes first Covid pill, from Pfizer, for emergency useBREAKING: FDA authorizes first Covid-19 antiviral pill in the US to protect against severe disease.
Baca lebih lajut »
Pfizer COVID treatment pill authorized by FDA
Baca lebih lajut »
Pfizer pill becomes 1st US-authorized home COVID treatment | AP NewsThe U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death. The announcement comes as the U.S. braces for a wave of new infections from the omicron variant.
Baca lebih lajut »
Pfizer Pill Becomes 1st US-Authorized Home COVID TreatmentPatients will need a positive COVID-19 test to get a prescription.
Baca lebih lajut »
FDA Authorizes Pfizer Antiviral Pill for COVID-19The FDA was also expected to authorize an antiviral pill from Merck, but as of Wednesday afternoon, only Pfizer's had been authorized for use.
Baca lebih lajut »
FDA authorizes Pfizer COVID antiviral pill for high-risk individualsThe Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19. Why it matters: At-home COVID-19 treatments, especially Pfizer's Paxlovid, are seen as possible game-changers for the pandemic. The emergency use authorization comes as the U.S. sees a surge in new COVID-19 cases and hospitalizations largely driven by the Omicron variant. Get market news worthy of your time with Axios Markets. Subscribe f
Baca lebih lajut »